← Holders
Nextech Invest Ltd.
What Nextech Invest Ltd. reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1595430 · Filed Nov 16, 2026
- Positions
- 18
- Reported value
- $2.2B
- Opened
- 4
- Closed
- 2
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$657M15 positions
- Dec 31, 2025$1B16 positions
- Mar 31, 2026$1.4B17 positions
- Jun 30, 2026$2.1B16 positions
- Sep 30, 2026$2.2B18 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
RVMDRevolution Medicines, Inc. | 7.6M | ±0% | $1.6B | 69.9% |
PBLSParabilis Medicines, Inc. | 4.7M | ±0% | $150.6M | 6.7% |
RLAYRelay Therapeutics, Inc. | 6.8M | ±0% | $122.3M | 5.5% |
ORICOric Pharmaceuticals, Inc. | 7.2M | ±0% | $96.5M | 4.3% |
TYRATyra Biosciences, Inc. | 3.4M | −3.0% | $75.4M | 3.4% |
ALMSAlumis Inc. | 4.6M | +28.5% | $33.6M | 1.5% |
ATTOAttovia Therapeutics, Inc. | 1.8M | New | $31.5M | 1.4% |
KYMRKymera Therapeutics, Inc. | 278.9K | ±0% | $31.2M | 1.4% |
ETRAElectra Therapeutics, Inc. | 2.6M | New | $29.7M | 1.3% |
ZYMEZymeworks Inc. | 1.1M | ±0% | $29.5M | 1.3% |
SLNSilence Therapeutics plc | 1.7M | +77.8% | $18.5M | 0.8% |
CTMXCytomX Therapeutics, Inc. | 4.4M | ±0% | $12.1M | 0.5% |
AVTXAvalo Therapeutics, Inc. | 766K | New | $11.7M | 0.5% |
GLUEMonte Rosa Therapeutics, Inc. | 761.2K | ±0% | $9.1M | 0.4% |
BRVEBraveheart Bio, Inc. | 416.7K | New | $8.4M | 0.4% |
CRVSCorvus Pharmaceuticals, Inc. | 450K | ±0% | $5.2M | 0.2% |
ENGNenGene Therapeutics Inc. | 2.3M | ±0% | $4.6M | 0.2% |
CNTXContext Therapeutics Inc. | 7.4M | ±0% | $2.2M | 0.1% |